[BMP signaling and bone formation].Clin Calcium. 2012 Nov; 22(11):1677-83.CC
Abstract
Bone morphogenetic proteins (BMPs) bind to two types of membrane receptors. Type II receptor phosphorylates type I receptor, then the phosphorylated type I receptor phosphorylates downstream effectors, such as Smads. Fibrodysplasia ossificans progressiva (FOP) is a rare autosomal dominant disorder characterized by progressive heterotopic ossification in skeletal muscle tissue. ALK2, a BMP type I receptor has been mutated in patients with FOP. The mutant ALK2 phosphorylates Smads in the absence of BMPs. In FOP, muscle injury may enhance BMP signaling via Smads to induce acute heterotopic ossification. Inhibitors of the BMP-Smad pathway will be useful to develop novel treatments for FOP.
Links
MeSH
Pub Type(s)
English Abstract
Journal Article
Review
Language
jpn
PubMed ID
23103811
Citation
Katagiri, Takenobu. "[BMP Signaling and Bone Formation]." Clinical Calcium, vol. 22, no. 11, 2012, pp. 1677-83.
Katagiri T. [BMP signaling and bone formation]. Clin Calcium. 2012;22(11):1677-83.
Katagiri, T. (2012). [BMP signaling and bone formation]. Clinical Calcium, 22(11), 1677-83. https://doi.org/CliCa121116771683
Katagiri T. [BMP Signaling and Bone Formation]. Clin Calcium. 2012;22(11):1677-83. PubMed PMID: 23103811.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - [BMP signaling and bone formation].
A1 - Katagiri,Takenobu,
PY - 2012/10/30/entrez
PY - 2012/10/30/pubmed
PY - 2013/3/21/medline
SP - 1677
EP - 83
JF - Clinical calcium
JO - Clin Calcium
VL - 22
IS - 11
N2 - Bone morphogenetic proteins (BMPs) bind to two types of membrane receptors. Type II receptor phosphorylates type I receptor, then the phosphorylated type I receptor phosphorylates downstream effectors, such as Smads. Fibrodysplasia ossificans progressiva (FOP) is a rare autosomal dominant disorder characterized by progressive heterotopic ossification in skeletal muscle tissue. ALK2, a BMP type I receptor has been mutated in patients with FOP. The mutant ALK2 phosphorylates Smads in the absence of BMPs. In FOP, muscle injury may enhance BMP signaling via Smads to induce acute heterotopic ossification. Inhibitors of the BMP-Smad pathway will be useful to develop novel treatments for FOP.
SN - 0917-5857
UR - https://www.unboundmedicine.com/medline/citation/23103811/[BMP_signaling_and_bone_formation]_
DB - PRIME
DP - Unbound Medicine
ER -
Latest evidence on COVID-19 from PubMed, WHO, CDC.
Visit free Relief Central.
Visit free Relief Central.
Try the Free App:
